Expression of UDP-glucuronosyltransferase 1A6 isoform in Caco-2 cells stimulated with lipopolysaccharide

Innate Immunity

Volumn 16, Issue 5, 2010, Pages 302-309

  Panaro, Maria Antonietta ^a   Cavallo, Pasqua ^a   Acquafredda, Angela ^a   Cianciulli, Antonia ^a   Calvello, Rosa ^a   Mitolo, Vincenzo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Caco 2 cells; lipopolysaccharide; mRNA; UDP glucuronosyltransferase; UGT1A6

Indexed keywords

ENDOTOXIN; GLUCURONOSYLTRANSFERASE 1A6; ISOPROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ARTICLE; CELL CULTURE; CELL STRAIN CACO 2; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; REGULATORY MECHANISM;

CACO-2 CELLS; ENZYME ACTIVATION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GLUCURONOSYLTRANSFERASE; HUMANS; INTESTINES; LIPOPOLYSACCHARIDES; METABOLIC DETOXICATION, DRUG;

BACTERIA (MICROORGANISMS); VERTEBRATA;

EID: 78649665028     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425909341909     Document Type: Article

References (43)

1. Meech R., Mackenzie PI Structure and function of uridine diphosphate glucuronosyltransferases. Clin Exp Pharmacol Physiol 1997 ; 24: 907-915.
2. Tephly T., Green M., Puig J., Irshaid Y. Endogenous substrates for UDP-glucuronosyltransferases. Xenobiotica 1988 ; 18: 1201-1210.
3. Tephly TR, Burchell B. UDP-glucuronosyltransferases: a family of detoxifying enzymes. Trends Pharmacol Sci 1990 ; 11: 276-279.
4. Mackenzie PI, Owens IS, Burchell B. et al. The UDP glycosyl-transferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 1997 ; 7: 255-269.
5. Gregory PA, Lewinsky RH, Gardner-Stephen DA, Mackenzie PI Regulation of UDP glucuronosyltransferases in the gastrointestinal tract. Toxicol Appl Pharmacol 2004 ; 199: 354-363.
6. Mackenzie PI Identification of uridine diphosphate glucuronosyltransferases involved in the metabolism and clearance of mycophenolic acid. Ther Drug Monit 2000 ; 22: 10-13.
7. Strassburg CP, Nguyen N., Manns MP, Tukey RH UDP-glucuronosyltransferase activity in human liver and colon. Gastroenterology 1999 ; 116: 149-160.
8. Strassburg CP, Nguyen N., Manns MP, Tukey RH Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol Pharmacol 1998 ; 54: 647-654.
9. Strassburg CP, Kneip S., Topp J. et al. Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine. Biol Chem 2000 ; 275: 36164-36171.
10. Strassburg CP, Oldhafer K., Manns MP, Tukey RH Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol Pharmacol 1997 ; 52: 212-220.
11. Strassburg CP, Manns MP, Tukey RH Expression of the UDP- glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem 1998 ; 273: 8719-8726.
12. Münzel PA, Bookjans G., Mehner G., Lehmköster T., Bock KW Tissue-specific 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible expression of human UDP-glucuronosyltransferase UGT1A6. Arch Biochem Biophys 1996 ; 335: 205-210.
13. Bock-Hennig BS, Kohle C., Nill K., Bock KW Influence of t-butylhydroquinone and beta-naphthoflavone on formation and transport of 4-methylumbelliferone glucuronide in Caco-2/TC-7 cell monolayers. Biochem Pharmacol 2002 ; 63: 123-128.
14. Münzel PA, Schmohl S., Buckle F. et al. Contribution of the Ah receptor to the phenolic antioxidant-mediated expression of human and rat UDP-glucuronosyltransferase UGT1A6 in Caco-2 and rat hepatoma 5L cells. Biochem Pharmacol 2003 ; 66: 841-847.
15. Ritter JK, Chen F., Sheen YY, Tran HM, Kimura S., Yeatman MT, Owens IS A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem 1992 ; 267: 3257-3261.
16. Boman HG Innate immunity and the normal microflora. Immunol Rev 2000 ; 173: 5-16.
17. Rousset M. The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. Biochimie 1986 ; 68: 1035-1040.
18. Bradford MM A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976 ; 72: 248-254.
19. Trubetskoy OV, Shaw PM A fluorescent assay amenable to measuring production of β-D-glucuronides produced from recombinant UDP-glycosyl transferase enzymes. Drug Metab Dispos 1999 ; 27: 555-557.
20. Ding AH, Nathan CF, Stuehr DJ Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988 ; 141: 2407-2412.
21. Rousset M., Laburthe M., Pinto M. et al. Enterocytic differentiation and glucose utilization in the human colon tumor cell line Caco-2: modulation by forskolin. J Cell Physiol 1985 ; 123: 377-385.
22. Zweibaum A., Triadou N., Kedinger M. et al. Sucrase-isomaltase: a marker of foetal and malignant epithelial cells of the human colon. Int J Cancer 1983 ; 32: 407-412.
23. Sabolovic N., Magdalou J., Netter P., Abid A. Nonsteroidal antiinflammatory drugs and phenols glucuronidation in Caco-2 cells: identification of the UDP-glucuronosyltransferases UGT1A6, 1A3 and 2B7. Life Sci 2000 ; 67: 185-196.
24. Grancharov K., Engelberg H., Naydenova Z., Müller G., Rettenmeier AW, Golovinsky E. Inhibition of UDP-glucuronosyltransferases in rat liver microsomes by natural mutagens and carcinogens. Arch Toxicol 2001 ; 75: 609-612.
25. Mulder GJ Glucuronidation and its role in regulation of biological activity of drugs. Annu Rev Pharmacol Toxicol 1992 ; 32: 25-49.
26. Ahotupa M., Mäntyla E. Comparison of the inducibilities of UDP-glucuronosyltransferase and polysubstrate monooxygenase activities in mice exposed to 20 model xenobiotics. Biochem Pharmacol 1983 ; 32: 2612-2615.
27. Castrén M., Oikari A. Changes of the liver UDP- glucuronosyltransferase activity in trout (Salmo gairdneri Rich.) acutely exposed to selected aquatic toxicants. Comp Biochem Physiol 1987 ; 86: 357-360.
28. Lawrence AJ, Michalkiewicz A., Morley JS, MacKinnon K., Billington D. Differential inhibition of hepatic morphine UDP-glucuronosyltransferases by metal ions. Biochem Pharmacol 1992 ; 43: 2335-2340.
29. Matsui M., Nagai F., Suzuki E., Okada M. Structure-activity relationships of nitrosamines and nitramines which stimulate UDP-glucuronosyltransferase activities in vitro. Biochem Pharmacol 1984 ; 33: 2647-2651.
30. Grancharov K., Naydenova Z., Lozeva S., Golovinsky E. Natural and synthetic inhibitors of UDP-glucuronosyltransferase. Pharmacol Ther 2001 ; 89: 171-186.
31. Mizuma T., Momota R., Haga M., Hayashi M. Factors affecting glucuronidation activity in Caco-2 cells. Drug Metab Pharmacokinet 2004 ; 19: 130-134.
32. Naganuma M., Saruwatari A., Okamura S., Tamura H. Turmeric and curcumin modulate the conjugation of 1-naphthol in Caco-2 cells. Biol Pharm Bull 2006 ; 29: 1476-1479.
33. Verhagen H., Schilderman PA, Kleinjans JC Butylated hydroxyanisole in perspective. Chem Biol Interact 1991 ; 80: 109-134.
34. Schilderman PA, Verhagen H., Schutte B., Ten Hoor F., Kleinjans JC Modulation by dietary factors of BHA-induced alterations in cell kinetics of gastro-intestinal tract tissues in rats. Food Chem Toxicol 1991 ; 29: 79-85.
35. Bishop A., Gallop PM, Karnovsky ML Pyrroloquinoline quinone: a novel vitamin? Nutr Rev 1998 ; 56: 287-293.
36. Buetler TM, Gallagher EP, Wang C., Stahl DL, Hayes JD, Eaton DL Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicol Appl Pharmacol 1995 ; 135: 45-57.
37. Ma Q., Kinneer K. Chemoprotection by phenolic antioxidants. Inhibition of tumor necrosis factor alpha induction in macrophages. J Biol Chem 2002 ; 277: 2477-2484.
38. Sherratt PJ, McLellan LI, Hayes JD Positive and negative regulation of prostaglandin E2 biosynthesis in human colorectal carcinoma cells by cancer chemopreventive agents. Biochem Pharmacol 2003 ; 66: 51-61.
39. Richardson TA, Sherman M., Kalman D., Morgan ET Expression of UDP-glucuronosyltransferase isoform mRNAs during inflammation and infection in mouse liver and kidney. Drug Metab Dispos 2006 ; 34: 351-353.
40. Heurtaux T., Benani A., Moulin D., Muller N., Netter P., Minn A. Induction of UGT1A6 isoform by inflammatory conditions in rat astrocytes. Neuropharmacology 2006 ; 50: 317-328.
41. Monshouwer M., Witkamp RF, Nujmeijer SM, Van Amsterdam JG, Van Miert AS Suppression of cytochrome P450-and UDP glucuronosyl transferase-dependent enzyme activities by proinflammatory cytokines and possible role of nitric oxide in primary cultures of pig hepatocytes. Toxicol Appl Pharmacol 1996 ; 137: 237-244.
42. Henderson B., Poole S., Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 1996 ; 60: 316-341.
43. Bhattacharyya J., Biswas S., Datta AG Mode of action of endotoxin: role of free radicals and antioxidants. Curr Med Chem 2004 ; 11: 359-368.